Table 4 Cost of diabetes complications Type II in 2009
From: Costs, outcomes and challenges for diabetes care in Spain
|  | Total direct costs (€ millions) | Direct cost per patient (€) | Components of direct costs (€ million, %) |
|---|---|---|---|
Macrovascular complications | €757.74 | €2776 | Pharmaceuticals €263.69 (34.8%) |
Inpatient €334.16 (44.1%) | |||
Outpatient€159.88 (21.1%) | |||
Microvascular complications | €579.79 | €1928 | Pharmaceuticals €241.19 (41.6%) |
Inpatient €189.59 (32.7%) | |||
Outpatient €149 (25.7%) | |||
Micro- and Macrovascular complications | €542.22 | €2930 | Pharmaceuticals €208.75 (38.5%) |
Inpatient €217.97 (40.2%) | |||
Outpatient €115.49 (21.3%) |